Log in

Amdocs Stock Price, News & Analysis (NASDAQ:DOX)

$65.36
-0.64 (-0.97 %)
(As of 10/15/2019 03:28 AM ET)
Today's Range
$65.32
Now: $65.36
$65.76
50-Day Range
$63.74
MA: $65.62
$66.74
52-Week Range
$52.60
Now: $65.36
$67.57
Volume287,700 shs
Average Volume872,909 shs
Market Capitalization$9.12 billion
P/E Ratio17.48
Dividend Yield1.73%
Beta0.39
Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company offers amdocsONE a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support, as well as consumer experience and monetization, media and digital, enterprise and connected society, service-driven network, and services and agile operation solutions. Read More…

Industry, Sector and Symbol

Industry Custom computer programming services
Sub-IndustryIT Consulting & Other Services
SectorComputer and Technology
Current SymbolNASDAQ:DOX
CUSIPG0260210
Phone1 314 212 7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.97 billion
Cash Flow$5.34 per share
Book Value$24.91 per share

Profitability

Net Income$354.39 million

Miscellaneous

Employees24,381
Market Cap$9.12 billion
Next Earnings Date11/14/2019 (Estimated)
OptionableOptionable

Receive DOX News and Ratings via Email

Sign-up to receive the latest news and ratings for DOX and its competitors with MarketBeat's FREE daily newsletter.


Amdocs (NASDAQ:DOX) Frequently Asked Questions

What is Amdocs' stock symbol?

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

How often does Amdocs pay dividends? What is the dividend yield for Amdocs?

Amdocs declared a quarterly dividend on Wednesday, August 7th. Shareholders of record on Monday, September 30th will be paid a dividend of $0.285 per share on Friday, October 25th. This represents a $1.14 annualized dividend and a yield of 1.74%. The ex-dividend date is Friday, September 27th. View Amdocs' Dividend History.

How will Amdocs' stock buyback program work?

Amdocs announced that its board has approved a share repurchase program on Thursday, November 9th 2017, which permits the company to repurchase $800,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's board of directors believes its stock is undervalued.

How were Amdocs' earnings last quarter?

Amdocs Limited (NASDAQ:DOX) issued its earnings results on Wednesday, August, 7th. The technology company reported $1.19 EPS for the quarter, topping the Zacks' consensus estimate of $1.11 by $0.08. The technology company earned $1.02 billion during the quarter, compared to analysts' expectations of $1.03 billion. Amdocs had a return on equity of 15.70% and a net margin of 9.90%. The company's revenue for the quarter was up 2.2% on a year-over-year basis. During the same quarter last year, the firm earned $1.03 earnings per share. View Amdocs' Earnings History.

When is Amdocs' next earnings date?

Amdocs is scheduled to release their next quarterly earnings announcement on Thursday, November 14th 2019. View Earnings Estimates for Amdocs.

What guidance has Amdocs issued on next quarter's earnings?

Amdocs issued an update on its FY 2019 earnings guidance on Wednesday, August, 7th. The company provided EPS guidance of $4.28-4.34 for the period, compared to the Thomson Reuters consensus estimate of $4.28. The company issued revenue guidance of $4.070233088-4.109981458 billion, compared to the consensus revenue estimate of $4.09 billion.

What price target have analysts set for DOX?

1 brokers have issued 12 month price targets for Amdocs' stock. Their forecasts range from $75.00 to $75.00. On average, they anticipate Amdocs' share price to reach $75.00 in the next twelve months. This suggests a possible upside of 14.7% from the stock's current price. View Analyst Price Targets for Amdocs.

What is the consensus analysts' recommendation for Amdocs?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Amdocs.

Has Amdocs been receiving favorable news coverage?

News stories about DOX stock have trended negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Amdocs earned a daily sentiment score of -2.8 on InfoTrie's scale. They also gave news stories about the technology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Amdocs.

Are investors shorting Amdocs?

Amdocs saw a decline in short interest in September. As of September 30th, there was short interest totalling 2,390,000 shares, a decline of 9.1% from the August 30th total of 2,630,000 shares. Based on an average daily volume of 589,600 shares, the short-interest ratio is currently 4.1 days. Currently, 1.8% of the company's shares are sold short. View Amdocs' Current Options Chain.

Who are some of Amdocs' key competitors?

What other stocks do shareholders of Amdocs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include QUALCOMM (QCOM), Home Depot (hd), Activision Blizzard (ATVI), Alphabet (GOOG), Micron Technology (MU), AbbVie (ABBV), Boeing (BA), Caterpillar (CAT), Chevron (CVX) and Enterprise Products Partners (EPD).

Who are Amdocs' key executives?

Amdocs' management team includes the folowing people:
  • Mr. Joshua Sheffer, Pres & CEO (Age 59)
  • Ms. Tamar Rapaport-Dagim, CFO & COO (Age 48)
  • Mr. Matthew E. Smith, Sec. & Head of Investor Relations (Age 47)
  • Mr. Gary Miles, Chief Marketing Officer
  • Darcy Antonellis, Head of Amdocs Media

Who are Amdocs' major shareholders?

Amdocs' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Denali Advisors LLC (0.07%), State of Alaska Department of Revenue (0.05%), Henry James International Management Inc. (0.01%), Nelson Van Denburg & Campbell Wealth Management Group LLC (0.01%), Arden Trust Co (0.01%) and Cerebellum GP LLC (0.01%).

Which institutional investors are selling Amdocs stock?

DOX stock was sold by a variety of institutional investors in the last quarter, including Denali Advisors LLC and Cerebellum GP LLC.

Which institutional investors are buying Amdocs stock?

DOX stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Henry James International Management Inc., Arden Trust Co, Cerebellum GP LLC and Nelson Van Denburg & Campbell Wealth Management Group LLC.

How do I buy shares of Amdocs?

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Amdocs' stock price today?

One share of DOX stock can currently be purchased for approximately $65.36.

How big of a company is Amdocs?

Amdocs has a market capitalization of $9.12 billion and generates $3.97 billion in revenue each year. The technology company earns $354.39 million in net income (profit) each year or $3.74 on an earnings per share basis. Amdocs employs 24,381 workers across the globe.View Additional Information About Amdocs.

What is Amdocs' official website?

The official website for Amdocs is http://www.amdocs.com/.

How can I contact Amdocs?

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]


MarketBeat Community Rating for Amdocs (NASDAQ DOX)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  509 (Vote Outperform)
Underperform Votes:  416 (Vote Underperform)
Total Votes:  925
MarketBeat's community ratings are surveys of what our community members think about Amdocs and other stocks. Vote "Outperform" if you believe DOX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DOX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Featured Article: Market Perform

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel